NHLBI Sickle Cell Sequencing
Closed Pre-Solicitation Posted
- Solicitation number
- 75N92022Q0475
- Agency
- National Heart Lung and Blood Institute National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- More information
Notice details come from SAM.gov. Updated .
About this opportunity
This pre-solicitation notice seeks sequencing services related to sickle cell disease. The National Heart, Lung, and Blood Institute of the National Institutes of Health within the Department of Health and Human Services will evaluate proposals to sequence DNA from patients with sickle cell disease to advance understanding of genetic modifiers of disease severity. Offerors must demonstrate expertise in whole genome or targeted sequencing and analysis of large sample cohorts. Proposals will be evaluated based on technical approach, qualifications, and ability to deliver results within 24 months of award. The question deadline is August 23, 2022.
There is no set-aside designation for this requirement. The anticipated NAICS code is 541715 and PSC code is R425. Incumbent contracts have been held by Illumina, Inc. and 23andMe, Inc. The government estimates a total budget between $5-10 million over a two year period to sequence the genomes of 5,000 sickle cell patients to identify genetic factors that influence clinical outcomes for this disease.
Notice text
NHLBI Sickle Cell Sequencing
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity